BCR-ABL1 TRANSCRIPT LEVEL ON DAY+28 CAN PREDICT EARLY MOLECULAR RESPONSE AT 3 MONTHS AND MAJOR MOLECULAR RESPONSE AT 12 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO TREATED WITH FRONTLINE DASATINIB

W. S. Lee, H. J. Kim, J. H. Kong,H. Kim,Y. R. Do, J. Y. Kwak, S. Oh,S. H. Kim, J. A. Kim,D. Y. Zang, Y. C. Moon,Y. W. Won, S. E. Lee,D. W. Kim

HAEMATOLOGICA(2016)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要